Mats Rudling
- Surgery top 1%
- Molecular Biology top 5%
- Epidemiology top 1%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Physiology top 1%
- Co-authors
- Bo AngelinCecilia GälmanThomas LundåsenKristina WalleniusSuzanne L. DicksonJohn‐Olov JanssonClaes OhlssonBo Åhrén
- Topics
- Cholesterol and Lipid Metabolism (31 papers)Drug Transport and Resistance Mechanisms (28 papers)Lipoproteins and Cardiovascular Health (15 papers)
- Partner nations
- SwedenUnited StatesAustralia
In The Last Decade
Mats Rudling
97 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Surgery 2.5k
- Molecular Biology 2.3k
- Epidemiology 2.0k
- Endocrinology, Diabetes and Metabolism 1.9k
- Physiology 1.5k
Countries citing papers authored by Mats Rudling
This map shows the geographic impact of Mats Rudling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Rudling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Rudling more than expected).
Fields of papers citing papers by Mats Rudling
This network shows the impact of papers produced by Mats Rudling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Rudling. The network helps show where Mats Rudling may publish in the future.
Co-authorship network of co-authors of Mats Rudling
This figure shows the co-authorship network connecting the top 25 collaborators of Mats Rudling. A scholar is included among the top collaborators of Mats Rudling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Rudling. Mats Rudling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 33 | |
| 2 | 4 | |
| 3 | 45 | |
| 4 | 80 | |
| 5 | 16 | |
| 6 | 39 | |
| 7 | 32 | |
| 8 | 1 | |
| 9 | 429 | |
| 10 | 104 | |
| 11 | 45 | |
| 12 | 11 | |
| 13 | 45 | |
| 14 | 359 | |
| 15 | 11 | |
| 16 | Interleukin-6-deficient mice develop mature-onset obesitybreakdown → | 987 |
| 17 | 23 | |
| 18 | 21 | |
| 19 | 81 | |
| 20 | 24 |
About Mats Rudling
Mats Rudling is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 97 papers that have together received 7.9k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (31 papers), Drug Transport and Resistance Mechanisms (28 papers) and Lipoproteins and Cardiovascular Health (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Endocrine and Autonomic Systems (423 citations) and Epidemiology (2.0k citations). Mats Rudling has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Bo Angelin, Cecilia Gälman, Thomas Lundåsen, Kristina Wallenius, Suzanne L. Dickson, John‐Olov Jansson, Claes Ohlsson, Bo Åhrén, Hans Carlsten and Ville Wallenius. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.